Abstract
Coxsackie B4 (CV-B4), is a major cause of viral myocarditis, dilated cardiomyopathy, and pancreatitis. Like other human enteroviruses, CV-B4 is ubiquitous, excreted in the stool, transmitted by fecal–oral route, and persists in the environment. In the context of studies on CV-B4 infection, it is important to investigate how this virus can be eliminated and to show the possibility of contamination risk with a CV-B4 E2 infected Swiss albino mice. Swiss albino female mice were inoculated with CV-B4 E2 strain and divided in two groups: the first was intraperitoneally (I.P.) infected; the second was orally infected. In order to study the CV-B4 E2 infection in mice, total RNA was extracted from thymus, spleen, pancreas, and intestine, and viral genome was detected using semi-nested (RT-PCR). To further demonstrate infection or immunization of mice, Sera obtained from infected mice were assayed in vitro for their neutralizing antibody. To detect virus in stool of infected mice, stool samples were collected at different post-infection (p.i.) times. Neutralizing antibodies were detectable all along the follow-up period (Day 0, 1, 3, 7, 9, 17, 22, 30, 45, 60 p.i.) in I.P and oral infected mice. Our results showed that when mice were inoculated successively at day 0 and day 8, neutralizing activity was increased in I.P route more than in the oral route. Viral isolation in HEp-2 cells showed negative results. Stool viral analyses reveal a low detection of the CV-B4 E2 genome for all infected mice. In conclusion, our experiments demonstrated that there are no risks linked with the stool of CV-B4 E2 of Swiss albino mice. It would be interesting to characterize the inhibitors of the virus infectivity in these biological samples (stool) and investigate their targets and mechanisms of action.
Similar content being viewed by others
References
Bahri O, Rezig D, Ben Nejma-Oueslati B, Ben Yahia A, Ben Sassi J, Hogga N, Sadraoui A, Triki H (2005) Enteroviruses in Tunisia: virological surveillance over 12 years (1992–2003). J Med Microbiol 54:63–69
Bendig JW, Franklin OM, Hebden AK, Backhouse PJ, Clewley JP, Goldman AP, Piggott N (2003) Coxsackievirus B3 sequences in the blood of a neonate with congenital myocarditis, plus serological evidence of maternal infection. J Med Virol 70(4):606–609
Bopegamage S, Borsanyiova M, Vargova A, Petrovicova A, Benkovicova M, Gomolcak P (2003) Coxsackievirus infection of mice I. Viral kinetics and histopathological changes in mice experimentally infected with coxscakievirus B3 and B4 by the oral route. Act Virol 47:245–251
Bopegamage S, Kovacova J, Vargova A, Motusova J, Petrovicova A, Benkovicova M, Gomolcak P, Bakkers J, van Kuppeveld F, Melchers WJG, Galama JM (2005) Coxsackie B virus infection of mice: inoculation by the oral route protects the pancreas from damage, but not from infection. J Gen Virol 86:3271–3280
Bruce-Chwatt LJ (1972) Blood transfusion and tropical disease. Trop Dis Bull. 69:825–862
Chomczynski P, Sacchi N (1987) Single-step method of isolation of RNA by acid guanidium thiocyanate-phenol-chlorophorm extraction. Anal Biochem 162:156–159
De Wazieres B, Gil H, Vuitton DA, Dupond JL (1998) Nosocomial transmission of dengue from a needle stick injury. Lancet 351(9101):498
Elmastour F, Jaidane H, Aguech-Oueslati L, Benkahla MA, Aouni M, Gharbi J, Sane F, Hober D (2016) Immunoglobulin G-dependent enhancement of the infection with coxsackievirus B4 in a murine system. Virulence 30:1–9
Elmastour F, Jaïdane H, Ben Kahla MA, Aguech-Oueslati L, Sané F, Aymen Halouani A, Engelmann I, Bertin A, Mokni M, Gharbi J, Aouni M, Alidjinou EK, Hober D (2016) Anti-coxsackievirus B4 (CV-B4) enhancing activity of serum associated with increased viral load and pathology in mice reinfected with CV-B4. Virulence. doi:10.1080/21505594.2016.1252018
Gaaloul I, Riabi S, Evans M, Hunter T, Huber S, Aouni M (2016) Coxsackievirus B heart infections and their putative contribution to sudden unexpected death: an 8-year review of patients and victims in the coastal region of Tunisia. Forensic Sci Int 268:73–80
Gauntt C, Trousdale M, La Badie D, Paque R, Nealon T (1979) Properties of coxsackievirus B3 variants which are amyocarditic or myocarditic for mice. J Med Virol 3:207–220
Herwaldt BL (2001) Laboratory-acquired parasitic infections from accidental exposures. Clin Microbiol Rev 14(4):659–688
Jaïdane H, Gharbi J, Lobert PE, Lucas B, Hiar R, M’hadheb MB, Brilot F, Geenen V, Aouni M, Hober D (2006) Prolonged viral RNA detection in blood and lymphoid tissues from coxsackievirus B4 E2 orally-inoculated Swiss mice. Microbiol Immunol 50(12):971–974
Jaïdane H, Sauter P, Sane F, Goffard A, Gharbi J, Hober D (2010) Enteroviruses and type 1 diabetes: towards a better understanding of the relationship. Rev Med Virol 20:265–280
Jaïdane H, Sané F, Gharbi J, Aouni M, Romond MB, Hober D (2009) Coxsackievirus B4 and type 1 diabetes pathogenesis: contribution of animal models. Diabetes Metab Res Rev 25:591–603
Jrad-Battikh N, Souii A, Oueslati L, Aouni M, Hober D, Gharbi J, Ben M’hadheb-Gharbi M (2014) Neutralizing activity induced by the attenuated coxsackievirus B3 Sabin3-like strain against CVB3 infection. Curr Microbiol 68(4):503–509
Knowles NJ, Hovi T, Hyypiä T, King AMQ, Lindberg M, Pallansch MA, Palmenberg AC, Simmonds P, Skern T, Stanway G (2012) Picornaviridae. In: King AMQ, Adams MJ, Carstens EB, LefkowitzEJ (eds) In virus taxonomy: classification and nomenclature of viruses: Ninth Report of the International Committee on taxonomy of viruses. Elsevier, San Diego, CA, pp 855–880
Leparc I, Aymard M, Acute Fuchs F (1994) Chronic and persistent enterovirus and poliovirus infections: detection of viral genome by seminested PCR amplification in culture-negative samples. Mol Cell 8:487–495
Lofstrom C, Knutsson R, Axelsson CE, Radstrom P (2004) Rapid and specific detection of Salmonella spp. in animal feed samples by PCR after culture enrichment. Appl Environ Microbiol 70:69–75
Melnick JL (1996) Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. In: Fields BN, Knipe DM (eds) Virology. Raven Press, New York, pp 549–605
Monteiro L, Bonnemaison D, Vekris A, Petry KG, Bonnet J, Vidal R (1997) Complex polysaccharides as PCR inhibitors in feces: Helicobacter pylori model. J Clin Microbiol 35:995–998
Oikarinen S, Tauriainen S, Viskari H, Simell O, Knip M, Virtanen S, Hyöty H (2009) PCR inhibition in stool samples in relation to age of infants. J Clin Virol 44(3):211–214
Othman I, Mirand A, Slama I, Mastouri M, Peigue Lafeuille H, Aouni M, Bailly J (2015) Enterovirus migration patterns between France and Tunisia. PLoS ONE 10(12):e0145674
Harrath R, Bourlet T, Dele´zay O, Douche-Aourik F, Omar S, Aouni M, Pozzetto B (2004) Coxsackievirus B3 replication and persistence in intestinal cells from mice infected orally and in the human CaCo-2 cell line. J Med Virol 74(2):283–290
Retoo KN, Osman SA, Illavia SJ, Cameron-Wilson CL, Banatvala JE, Muir P (2001) Quantitative analysis of viral RNA kinetic in coxsackievirus B3-induced murine myocarditis: biphasic pattern of clearance following acute infection with persistence of residual viral RNA throughout and beyond the inflammatory phase of disease. J Gen Virol 81(Pt11):2755–2762
Reed LJ, Muench H (1938) A simple method of estimating fifty percent end points. Am J Hyg 27:493–497
Rotbart HA, Hayden FG (2001) Picornavirus infections. Arch Fam Med 9:913–920
Seeff LB (1991) Hepatitis C from a needle stick injury. Ann Intern Med 115(5):411
Welch JB, McGowan K, Searle B, Gillon J, Jarvis LM, Simmonds P (2001) Detection of enterovirus viraemia in blood donors. Vox Sang 80:211–215
Yeung W-CG, Rawlinson WD, Craig ME (2011) Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. BMJ 342:d35
Yoon JW, Austin M, Onodera T (1979) Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 300:1173–1179
Acknowledgements
Leila Aguech-Oueslati was supported by the Comité Mixte de Coopération Universitaire Franco-Tunisian (CMCU 08/G808) with grants from Egide Paris. This work was supported by the Ministry for Scientific Research, Technology and the Development of Competencies, (LR99ES27), Tunisia, Ministry for the National Education of Research and Technology, Université de Lille, et CHU de Lille Laboratoire de Virologie EA3610, F-59037, Lille, France.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Aguech-Oueslati, L., Jaidane, H., Sane, F. et al. Evaluation of Contamination Risks with Coxsackievirus B4 E2 in Swiss Albino Mice Stools. Curr Microbiol 75, 32–39 (2018). https://doi.org/10.1007/s00284-017-1347-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00284-017-1347-2